Lineage Cell Therapeutics, Inc. (LCTX)
1.81
+0.03
(+1.69%)
USD |
NYAM |
Feb 20, 16:00
1.81
0.00 (0.00%)
After-Hours: 20:00
Lineage Cell Therapeutics EPS Diluted (Quarterly) : -0.1301 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nephros, Inc. | 0.0305 |
| ProKidney Corp. | -0.122 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -29.75M |
| Revenue (Quarterly) | 3.681M |
| Total Expenses (Quarterly) | 33.46M |
| Enterprise Value | 377.78M |
| Gross Profit Margin (Quarterly) | 95.03% |
| Profit Margin (Quarterly) | -808.3% |
| Earnings Yield | -16.39% |
| Normalized Earnings Yield | -8.006 |